Clinical Trials Browser

Phase 1/2 × Malignant Solid Tumour × Other solid neoplasm × Clear all

NCT02857920 2020-09-14

Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Malignant Solid Tumour

NCT02843204 2020-05-28

Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Malignant Solid Tumour

NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Phase 1/2 Completed

49 enrolled 12 charts

GastrointestinalOther solid neoplasm

Malignant Solid Tumour